New screening tool aims to spot suicide risk in kids with autism
NCT ID NCT04317118
First seen Jun 27, 2026 · Last updated Sep 10, 2026 · Updated 2 times
Summary
This study tested a set of questions to better identify suicide risk in young people aged 8–17 with autism or other neurodevelopmental disorders. Researchers asked 278 participants and their parents about thoughts of self-harm and understanding of death. The goal was to create a reliable screening tool for clinics, since no standard method currently exists for this group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
278 people
The number who actually took part.
- Started
-
Jul 2021
- Finished
-
Sep 2025
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Individuals in either inpatient or outpatient behavioral health settings or research settings.
- Ages
-
8 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Participants must be engaged in assessment or treatment in one of the inpatient or outpatient medical health settings from one of the study site hospitals that are part of this protocol. * Participants must be verbally fluent and have the ability to communicate verbally. This will, in part, be determined by one of the patient s clinicians or trained study staff, who will also be an associate investigator for this study and will already have routine access to information regarding the patient s verbal fluency. * If the parent/patient expresses interest in participating in a research study, verbal fluency will be further confirmed by asking the parents if the child is verbally fluent (e.g. regularly speaks in sentences), asking the parent if their child will be able to understand and answer the study questions, and by observing the subject as they are explaining the study. The observation will entail taking a verbatim language sample if needed and discussing the decision about whether the child meets this verbal fluency criteria with a study supervisor if needed. The data collectors will be at least high school graduates and over the age of 18 and be trained in assessing fluency level through parent interview and observation. They will also be trained to understand the presentation of individuals with ASD, as well as in how to respond if the child is noncompliant or presents with suicidal thoughts and behaviors. * Age 8 years to 17. * English speaking child and parent; may use an Augmentative and Alternative Communication (AAC) device to assist. * A legal guardian must provide permission and participant must sign an assent document or provide verbal assent. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * The parent or the legal guardian is unavailable/unwilling to sign consent. * The participant will not have prisoner status, e.g. not on probation or house arrest INCLUSION OF VULNERABLE PARTICIPANTS: -Children: Children and adolescents with ASD/NDD are the focus of the study due to the lack of suicide risk screening tools available for this general population. Clients who do not speak English will be excluded from the study. Unfortunately, the screening tools that will be utilized in this study are not available at this time in any other languages besides English. OTHER VULNERABLE POPULATIONS: The study sites include health clinic or psychiatric units that serve children, adolescents or adults with ASD/NDD. Currently these sites service suicidal individuals and no validated instrument with which to assess these vulnerable individuals.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kennedy Krieger Institute/Johns Hopkins University
Baltimore, Maryland, 21205, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
Nationwide Children's Hospital/ Ohio State University
Columbus, Ohio, 43201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a short, Family-Focused program replace hospital stays for suicidal teens?
- Can a website persuade men in crisis to ask for help?
- Can a tailored therapy ease anxiety and depression in autistic teens?
- Can coaching school staff raise the quality of autism programs?
- Can wireless monitors make ER vitals easier for autistic children?